We focused our attention on docetaxel since: a) it represents the treatment of choice for CRPC [4], [5]; b) it has been shown to induce tumor cell death through upregulation of the proapoptotic protein Bax and downregulation of the antiapoptotic protein Bcl-2 [8], [9]. The gene discussed is BCL2; the disease is neoplasm.